6Liver Failure and Artficial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association.肝衰竭诊疗指南[J].实用肝脏病杂志,2006,9(6):321-324. 被引量：190
7Dhiman RK, Seth AK, Jain S, et al. Prognositic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci,1998,43(6) : 1311-1316.
8Humar A, Khwaja K, Glessing B, et al. Regionwide sharing for status I liver patients--beneficial impact on waiting time and pre- and posttransplant survival. Liver Transpl, 2004, 10 ( 5 ) : 661-665.
9Freeman RB. The impact of the model for end-stage liver disease on recipient selection for adult living liver donation. Liver Transpl, 2003,9 ( 10 Suppl 2) : S54-59.
10Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatol, 2002,36(2) :451-455.
